A Biocompatible Arginine-Based Polycation
Self assembly between cations and anions is ubiquitous throughout nature. Important biological structures such as chromatin often use polyvalent assembly between a polycation and a polyanion. The biomedical importance of synthetic polycations arises from their affinity to polyanions such as nucleic...
Saved in:
Published in | Advanced functional materials Vol. 21; no. 3; pp. 434 - 440 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
WILEY-VCH Verlag
08.02.2011
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Self assembly between cations and anions is ubiquitous throughout nature. Important biological structures such as chromatin often use polyvalent assembly between a polycation and a polyanion. The biomedical importance of synthetic polycations arises from their affinity to polyanions such as nucleic acid and heparan sulfate. However, the limited biocompatibility of synthetic polycations hampers the realization of their immense potential. By examining biocompatible cationic peptides, we hypothesize that a biocompatible polycation should be biodegradable and made from endogenous cations. We design an arginine‐based biodegradable polycation and demonstrate that it is more compatible by several orders of magnitude than conventional polycations in vitro and in vivo. This biocompatibility diminishes when L‐arginine is substituted with D‐arginine or when the biodegradable ester linker is changed to a biostable ether linker. We believe that this design can lead to many biocompatible polycations that can significantly advance a wide range of applications including controlled release, tissue engineering, biosensing, and medical devices.
The design of PAGS and the control polymers that probe the importance of endogenous cations and their degradability in terms of biocompatibility is studied. The biocompatibility is shown to diminish when L‐arginine is substituted with D‐arginine or when the biodegradable ester linker is changed to a biostable ether linker. |
---|---|
Bibliography: | istex:6EBB0DF84B98F298D143C9EAB73FFDE1CE9174F1 ark:/67375/WNG-12K0WRW9-G ArticleID:ADFM201000969 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1616-301X 1616-3028 1616-3028 |
DOI: | 10.1002/adfm.201000969 |